| # | Drug | Count |
|---|---|---|
| 0 | BEVACIZUMAB | 4 |
| 1 | TACROLIMUS | 4 |
| 2 | PREDNISOLONE | 3 |
| 3 | PREDNISOLONE ORAL | 3 |
| 4 | PREDNISOLONE ORAL SOLUTION | 3 |
| 5 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 3 |
| 6 | TACROLIMUS OINTMENT 0.1% | 3 |
| 7 | ASPIRIN | 2 |
| 8 | ASPIRIN 325 MG | 2 |
| 9 | ASPIRIN 81 MG | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DOSTARLIMAB | 1 | 0.0004 |
| 1 | IMMUNE GLOBULIN INFUSION (HUMAN), 10% WITH RECOMBINANT HUMAN HYALURONIDASE | 1 | 0.0002 |
| 2 | AVELUMAB | 1 | 0.0002 |
| 3 | APREPITANT | 1 | 0.0001 |
| 4 | LAMIVUDINE AND ZIDOVUDINE | 1 | 0.0001 |
| 5 | ENFORTUMAB VEDOTIN | 1 | 0.0001 |
| 6 | EVEROLIMUS TABLETS | 2 | 0.0001 |
| 7 | ASFOTASE ALFA | 1 | 0.0001 |
| 8 | MYCOPHENILIC ACID | 2 | 0.0001 |
| 9 | LOPINAVIR AND RITONAVIR | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 1 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 1 | 0.0001 |
| 2 | Antimetabolite Immunosuppressant [EPC] | 2 | 0.0001 |
| 3 | Programmed Death Ligand-1 Blocker [EPC] | 2 | 0.0001 |
| 4 | Protease Inhibitor [EPC] | 1 | 0.0000 |
| 5 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 4 | 0.0000 |
| 6 | Epidermal Growth Factor Receptor Antagonist [EPC] | 1 | 0.0000 |
| 7 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 2 | 0.0000 |
| 9 | Parathyroid Hormone Analog [EPC] | 2 | 0.0000 |